ArticleScientific reports2026
APASA: adaptive selection of informative peritumoral regions for improved automated cancer lesion analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Precise cancer lesion analysis in medical imaging critically depends on the accurate definition of regions of interest (ROIs), which directly influence diagnostic and clinical outcomes. While peritumoral features are known to enhance lesion characterization, efficiently defining meaningful peritumoral ROIs remains a challenge. We propose an adaptive peritumoral area selection approach (APASA) that systematically identifies the most informative ROI surrounding a lesion, enabling the extraction of meaningful radiomic features for improved diagnostic performance. Unlike conventional heuristic or morphology-based methods, APASA leverages the minimum coverage graph algorithm, using the tumor ROI as a reference to construct a graph encompassing both the tumor and its peritumoral microenvironment. The effectiveness of the proposed approach was evaluated within AI-based frameworks for automated lesion differentiation in breast and thyroid cancers. Extensive experiments employing five widely used machine learning models demonstrated that APASA-selected peritumoral features consistently outperformed conventional morphological dilation. Performance improvements reached up to 30.75% in AUC and 29.00% in F1-score compared with the tumor ROI baseline. Moreover, the optimal model was found to vary depending on the ROI type, shape, and cancer type, offering new insights into the interaction between ROI selection and model choice. These results highlight APASA as a principled and efficient strategy for adaptive ROI definition in ultrasound-based cancer lesion analysis, demonstrating effectiveness across two ultrasound datasets, with potential extension to other imaging modalities and clinical settings pending further validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.